Total current assets Total assets Total current liabilities Total liabilities Total stockholders’ equity Balance Balance Total liabilities and stockholders’ equity Total operating expenses Loss from operations Total other income, net Loss before income tax expense Net loss Net loss Total comprehensive loss Total comprehensive loss for the year Balance (in Shares) Balance (in Shares) Equity Components [Axis] Net cash used in operating activities Net cash used in investing activities Net cash provided by financing activities Net decrease in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Re-domiciliation and Business [Abstract] Consolidated Entities [Axis] Basis of Presentation and Summary of Significant Accounting Policies [Abstract] Prepaid Expenses and Other Current Assets [Abstract] Total prepaid expenses and other current assets Prepaid expenses and other assets R&D Tax Incentive Receivable [Abstract] Property, Plant and Equipment, Net [Abstract] Total property, plant and equipment, gross Total property, plant and equipment, net Property, plant and equipment, net Trade and Other Payables, Accrued Expenses and Other Current Liabilities [Abstract] Total trade and other payables Trade and other payables Total accrued expenses and other current liabilities Accrued expenses and other current liabilities Total Trade and other payables, accrued expenses and other current liabilities Leases [Abstract] Schedule of Lease Costs [Abstract] Schedule of Future Minimum Lease Payments [Abstract] Total minimum lease payments Total operating lease liabilities Commitments and Contingencies [Abstarct] Stockholder’s Equity/Issued Capital [Abstract] Stock-Based Payments [Abstract] Statement of Income Location, Balance [Axis] Numbers of Shares, Unvested and Outstanding Beginning Numbers of Shares, Unvested and Outstanding Ending Number of Shares, Unvested as of September 30, 2024 Weighted Average Grant Date Fair Value, Unvested and Outstanding Beginning Weighted Average Grant Date Fair Value, Unvested and Outstanding Ending Weighted Average Exercise Price, Unvested as of September 30, 2024 Number of Shares, Outstanding, balance Weighted Average Exercise Price, Outstanding balance Income Tax [Abstarct] Loss Per Share [Abstract] Schedule of Basic and Diluted Net Loss Per Share Attributable to Shareholders [Abstract] Related Party Transactions [Abstract] Subsequent Events [Abstract] Assets Current assets: Cash and cash equivalents Research and Development (“R&D”) tax incentive receivable R&D tax incentive receivable Operating lease right-of-use assets Liabilities and stockholders’ equity Current liabilities: Current liabilities Operating lease liabilities, current Operating lease liabilities, non-current Commitments and contingencies (Note 8) Stockholders’ equity: Common Stock, $0.0001 par value per share – 100,000,000 shares authorized; 17,642,832 and 17,642,832 shares issued and outstanding at September 30, 2024 and June 30, 2024, respectively Common stock, par value (in Dollars per share) Common stock, par value Common stock, shares authorized Common stock, shares issued Shares of common stock Common stock, shares outstanding Preferred Stock, $0.0001 par value per share, 10,000,000 shares authorized; no shares issued or outstanding at September 30, 2024 and June 30, 2024, respectively Preferred stock, par value per share (in Dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Additional paid-in capital Accumulated deficit Foreign currency translation reserve Revenue from customers Operating expenses: Other income, net: R&D tax incentive Foreign exchange gains/(losses) Interest income Other comprehensive income/(loss): Currency translation adjustment, net of tax Net loss per share: Basic and diluted (in Dollars per share) Basic loss per share (dollars per share) Net loss per share, diluted (in Dollars per share) Diluted loss per share Weighted average number of shares outstanding, basic and diluted (in Shares) Weighted average number of common stock (number) Weighted average number of shares outstanding, diluted (in Shares) Stock-based compensation Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Share-based compensation expense Change in operating assets and liabilities: Trade and other payables Accrued expenses and other current liabilities Cash flows from investing activities: Cash flows from financing activities: Effect of exchange rate changes on cash and cash equivalents Research and development General and administrative Income tax expense Repayment of lease liabilities Unrealized loss on foreign currency remeasurement Prepaid expenses and other current assets R&D tax incentive Purchase of property, plant and equipment Repayment of lease liabilities Common Stock Common Stock [Member] Additional paid-in capital Accumulated deficit Foreign currency translation reserve Re-domiciliation and Business Schedule of Condensed Consolidated Financial Statements Jurisdiction Basis of Presentation and Summary of Significant Accounting Policies Prepaid expenses and other current assets Schedule of Prepaid Expenses and Other Current Assets Prepayments GST recoverable R&D tax incentive receivable Schedule of R&D Tax Incentive Receivable Property, Plant and Equipment, net Schedule of Property, Plant and Equipment, Net Furniture, fittings and equipment Assets under construction Trade and other payables, accrued expenses and other current liabilities Schedule of Trade and Other Payables, Accrued Expenses and Other Current Liabilities Trade payables Contract liabilities Accrued expenses Employee leave entitlements Leases Schedule of Weighted-Average Remaining Lease Term and Discount Rates Lease term (years) Weighted-average remaining lease term Discount rate Weighted-average remaining discount rate Schedule of Lease Costs Operating lease cost Schedule of Future Minimum Lease Payments June 30, 2025 June 30, 2026 June 30, 2027 June 30, 2028 Less amount representing interest Commitments and contingencies Stockholder’s equity/Issued capital Stock-based payments Schedule of Stock-Based Payments Schedule of Restricted Stock Numbers of Shares, Granted Number of Shares, Granted Weighted Average Grant Date Fair Value, Granted Numbers of Shares, Forfeited Weighted Average Grant Date Fair Value, Forfeited Schedule of Stock Options Weighted Average Remaining Contractual Term, Outstanding balance Aggregate Intrinsic Value (in thousands), Outstanding balance Weighted Average Exercise Price, Granted Aggregate Intrinsic Value (in thousands), Granted Number of Shares, Exercised Weighted Average Exercise Price, Exercised Aggregate Intrinsic Value (in thousands), Exercised Number of Shares, Cancelled or forfeited Weighted Average Exercise Price, Cancelled or forfeited Weighted Average Remaining Contractual Term, Cancelled or forfeited Aggregate Intrinsic Value (in thousands), Cancelled or forfeited Weighted Average Remaining Contractual Term, Unvested as of September 30, 2024 Aggregate Intrinsic Value (in thousands), Unvested as of September 30, 2024 Income Tax Loss per share Schedule of Basic and Diluted Net Loss Per Share Attributable to Shareholders The loss and weighted average number of common stock used in the calculation of basic loss per share is as follows: Related Party Transactions Subsequent Events Accumulated depreciation and amortization Total stock-based compensation expense Numbers of Shares, Vested Weighted Average Grant Date Fair Value,Vested Incannex Healthcare Limited [Member] Incannex Pty Ltd [Member] Psychennex Pty Ltd [Member] APIRx Pharmaceutical USA, LLC [Member] APIRx Pharmaceuticals Holding BV [Member] Clarion Clinics Group Pty Ltd [Member] Clarion Model Clinic Pty Ltd [Member] Psychennex Licensing and Franchising Pty Ltd [Member] Research and development [Member] General and administrative [Member] Restricted Stock [Member] Related and Nonrelated Parties [Axis] Class of Stock [Axis] Scenario [Axis] Lender Name [Axis] Subsequent Event Type [Axis] Class of Warrant or Right [Axis] Debt Instrument [Axis] Number of ordinary shares traded Number of share received Depreciation expense Operating lease liabilities Vote per share Unrecognized compensation cost Weighted-average period Payable to any related parties Term loan facility (in Dollars) Initial drawdown amount (in Dollars) Loan facility interest, percentage Percentage of research and development expenses Shares of common stock (in Dollars) Number of trading days Number of warrants exercisable Exercise price per share (in Dollars per share) Number of shares committed Number of warrants Outstanding shares of common stock percentage Principal amount (in Dollars) Aggregate purchase price (in Dollars) Original issue discount percentage Interest rate Number of warrant issued Net proceeds received (in Dollars) Shares of common stock Basis of Presentation Unaudited Interim Financial Information Going Concern Basis Principles of Consolidation Use of Estimates Risks and Uncertainties Significant Accounting Policies Incannex Australia [Member] Incannex Healthcare Limited [Member] Related Party [Member] Forecast [Member] ELOC Agreement [Member] Subsequent Event [Member] ELOC Warrant [Member] Arena Investors, LP [Member] First Tranche Debenture [Member] First Tranche Warrant [member] Warrant [Member] Equity Component [Domain] Statement [Table] Statement [Line Items] Consolidated Entities [Domain] Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] R&D Tax Incentive Receivable (Details) - Schedule of R&D Tax Incentive Receivable [Table] Schedule of R&D Tax Incentive Receivable [Abstract] Statement of Income Location, Balance [Domain] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule of Share-Based Compensation Expense [Line Items] Award Type [Domain] Stock-Based Payments (Details) - Schedule of Restricted Stock [Table] Schedule of Restricted Stock [Line Items] Stock-Based Payments (Details) - Schedule of Stock Options [Table] Schedule of Stock Options [Line Items] Class of Stock [Domain] Related and Nonrelated Parties [Domain] Re-domiciliation and Business (Details) [Table] Re-domiciliation and Business [Line Items] Stockholder's Equity/Issued Capital (Details) [Table] Class of Stock [Line Items] Related Party Transactions (Details) [Table] Related Party Transactions [Line Items] Scenario [Domain] Subsequent Event Type [Domain] Line of Credit Facility, Lender [Domain] Class of Warrant or Right [Domain] Debt Instrument, Name [Domain] Subsequent Events (Details) [Table] Subsequent Events [Line Items] Amount of GST recoverable. Disclosure of accounting policy for going concern basis. Represent the amount of increase decrease in research and development tax incentive receivable. Represent the number of shares traded in security exchange. Represent the number of share received. Number of shares committed. Number of trading days. Number of warrant issued. Number of warrants exercisable. Percentage of original issue discount percentage. Outstanding shares of common stock percentage. The amount of repayment of lease liabilities. Percentage of research and development expenses. Represent the amount of R&D tax incentive. Disclosure of R&D tax incentive receivable. Amount of repayment of lease liabilities. Tabular disclosure of R&D Tax Incentive Receivable. Tabular disclosure of weighted-average remaining lease term and discount rates. Aggregate Intrinsic Value Cancelled or forfeited. Amount of accumulated difference between fair value of underlying shares on dates of exercise granted on options (or share units converted) into shares. Weighted average remaining contractual term for option awards nonvested, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Weighted average remainingcContractual term, cancelled or forfeited. Amount of trade and other payables, accrued expenses and other current liabilities. Wholly owned subsidiary jurisdiction. Schedule Of Restricted Stock Abstract Use of Estimates, Policy [Policy Text Block] Assets [Abstract] Commitments and Contingencies Nonoperating Income (Expense) [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Common Stock, Value, Issued Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Earnings Per Share, Diluted Number Of Ordinary Shares Traded Retained Earnings [Member] Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Schedule Of Weighted Average Remaining Lease Term And Discount Rates Table Text Block Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule Of Trade And Other Payables Accrued Expenses And Other Current Liabilities Abstract Weighted Average Number of Shares Outstanding, Basic Increase (Decrease) in Prepaid Expense and Other Assets The Loss And Weighted Average Number Of Common Stock Used In The Calculation Of Basic Loss Per Share Is As Follows Abstract Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Schedule Of RDTax Incentive Receivable Table Text Block Stock Issued During Period, Value, New Issues Statement of Stockholders' Equity [Abstract] Basis of Accounting, Policy [Policy Text Block] Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Other Comprehensive Income (Loss), Tax [Abstract] Number Of Warrants Exercisable Income Tax Expense (Benefit) Research and Development Expense [Member] Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Income Statement [Abstract] Accounts Payable, Trade Lessee, Operating Leases [Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Investment Income, Interest APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Additional Paid in Capital Operating Expenses [Abstract] Trade And Other Payables Accrued Expenses And Other Current Liabilities Share Based Compensation Arrangement By Share Based Payment Award Option Forfeitures Intrinsic Value Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Earnings Per Share, Basic Accounts Payable and Other Accrued Liabilities, Current Net Cash Provided by (Used in) Operating Activities [Abstract] Assets Liabilities Common Stock, Voting Rights Research and Development Expense Equity, Attributable to Parent [Abstract] Preferred Stock, Shares Issued Subsequent Events [Text Block] Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Original Issue Discount Percentage Schedule Of Stock Based Payments Abstract Forecast [Member] Prepaid Insurance Common Stock, Shares, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Retained Earnings (Accumulated Deficit) Sharebased Compensation Arrangement By Sharebased Payment Weighted Average Remaining Contractual Term Cancelled Or Forfeited Lessee, Operating Lease, Liability, to be Paid, Year Three APIRx Pharmaceutical USALLCMember Depreciation Net Cash Provided by (Used in) Investing Activities Gain (Loss), Foreign Currency Transaction, before Tax Other Liabilities Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Term Unvested Payments to Acquire Property, Plant, and Equipment Business Description and Basis of Presentation [Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Proceeds from Lines of Credit Preferred Stock, Shares Authorized Number Of Warrant Issued Preferred Stock, Shares Outstanding Prepaid Expense and Other Assets, Current Property, Plant and Equipment, Net Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Net Cash Provided by (Used in) Financing Activities RDTax Incentive APIRx Pharmaceuticals Holding BVMember Common Stock, Shares Authorized Property, Plant and Equipment, Gross Construction in Progress, Gross Employee-related Liabilities, Current Operating Lease, Liability, Noncurrent Operating Lease, Weighted Average Discount Rate, Percent Subsequent Event [Member] Warrant [Member] Furniture and Fixtures, Gross Repayment Of Lease Liabilities Going Concern Basis Policy Text Block Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Share-Based Payment Arrangement, Expense Increase (Decrease) in Operating Capital [Abstract] Net Cash Provided by (Used in) Financing Activities [Abstract] Additional Paid-in Capital [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Restricted Stock [Member] Operating Income (Loss) Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Aggregate Intrinsic Value Net Cash Provided by (Used in) Investing Activities [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Operating Lease, Liability Outstanding Shares Of Common Stock Percentage Proceeds from Issuance of Debt Depreciation, Depletion and Amortization, Nonproduction Accrued Liabilities and Other Liabilities Common Stock [Member] Payment Of Lease Liabilities Statement of Cash Flows [Abstract] Class of Warrant or Right, Outstanding Percentage Of Research And Development Expenses Operating Lease, Liability, Current Lessee, Operating Lease, Liability, to be Paid, Year Two Income Tax Disclosure [Text Block] Comprehensive Income (Loss), Net of Tax, Attributable to Parent Line of Credit Facility, Commitment Fee Percentage Schedule Of Condensed Consolidated Financial Statements Abstract Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Related Party Transactions Disclosure [Text Block] Incannex Healthcare Limited Member Arena Investors LPMember Liabilities, Current [Abstract] Net Cash Provided by (Used in) Operating Activities First Tranche Debenture Member Increase Decreasein RDTax Incentive Receivable Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] ELOCWarrant Member General and Administrative Expense [Member] Operating Lease, Weighted Average Remaining Lease Term Share-Based Payment Arrangement [Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block] Unusual Risks and Uncertainties [Table Text Block] Equity, Attributable to Parent Increase (Decrease) in Accounts Payable and Accrued Liabilities Earnings Per Share [Text Block] Incannex Australia Member Accumulated Other Comprehensive Income (Loss), Net of Tax Long-Term Line of Credit Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Revenues Operating Lease, Cost Other Receivables, Net, Current Schedule Of Stock Options Abstract General and Administrative Expense Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Number Of Share Received Clarion Model Clinic Pty Ltd Member Contract with Customer, Liability, Current Common Stock, Par or Stated Value Per Share GSTRecoverable Common Stock, Shares, Issued Lease, Cost [Table Text Block] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Proceeds from Issuance of Private Placement Weighted Average Number of Shares Outstanding, Diluted Property, Plant and Equipment Disclosure [Text Block] Incannex Pty Ltd Member Basis of Presentation and Significant Accounting Policies [Text Block] Wholly Owned Subsidiary Jurisdiction Lessee, Operating Lease, Liability, to be Paid Related Party [Member] Share-Based Payment Arrangement, Option, Activity [Table Text Block] Equity [Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Debt Instrument, Face Amount Assets, Current [Abstract] Property, Plant and Equipment [Table Text Block] Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Liabilities, Current Operating Expenses Number Of Shares Committed ELOCAgreement Member Statement of Financial Position [Abstract] Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and Cash Equivalents, at Carrying Value Schedule Of RDTax Incentive Receivable Abstract Other Current Assets [Text Block] Accrued Liabilities, Current Consolidation, Policy [Policy Text Block] Liabilities and Equity [Abstract] Shares, Outstanding Commitments and Contingencies Disclosure [Text Block] Number Of Trading Days Lessee, Operating Lease, Liability, to be Paid, Year One Psychennex Pty Ltd Member Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Operating Lease, Lease Income Incannex Healthcare Pty Ltd Member Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Psychennex Licensing And Franchising Pty Ltd Member Warrant, Exercise Price, Decrease Preferred Stock, Value, Issued Clarion Clinics Group Pty Ltd Member Liabilities and Equity Lessee, Operating Lease, Liability, Undiscounted Excess Amount Nonoperating Income (Expense) Share-Based Payment Arrangement, Noncash Expense Debt Instrument, Interest Rate During Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Disposal Group, Including Discontinued Operations RDTax Incentive Receivable Text Block Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Preferred Stock, Par or Stated Value Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Consolidation, Variable Interest Entity, Policy [Policy Text Block] Operating Lease, Right-of-Use Asset Excess Stock, Shares Issued Assets, Current